These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

472 related items for PubMed ID: 12486437

  • 1. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study.
    Burger AJ, Horton DP, LeJemtel T, Ghali JK, Torre G, Dennish G, Koren M, Dinerman J, Silver M, Cheng ML, Elkayam U, Prospective Randomized Evaluation of Cardiac Ectopy with Dobutamine or Natrecor Therapy.
    Am Heart J; 2002 Dec; 144(6):1102-8. PubMed ID: 12486437
    [Abstract] [Full Text] [Related]

  • 2. Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure.
    Aronson D, Burger AJ.
    Am Heart J; 2004 Nov; 148(5):e16. PubMed ID: 15523294
    [Abstract] [Full Text] [Related]

  • 3. Dobutamine effects on spontaneous variability of ventricular arrhythmias in patients with severe chronic heart failure: the Italian Multicenter Study.
    Puddu PE, Papalia U, Schiariti M, Usta C, Do.S.I.M. Investigators of the Italian Interuniversity Cardiology Group.
    Ital Heart J; 2004 Sep; 5(9):693-701. PubMed ID: 15568599
    [Abstract] [Full Text] [Related]

  • 4. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.
    Colucci WS, Elkayam U, Horton DP, Abraham WT, Bourge RC, Johnson AD, Wagoner LE, Givertz MM, Liang CS, Neibaur M, Haught WH, LeJemtel TH.
    N Engl J Med; 2000 Jul 27; 343(4):246-53. PubMed ID: 10911006
    [Abstract] [Full Text] [Related]

  • 5. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM, Crouch MA, Carroll NV, Oinonen MJ.
    Pharmacotherapy; 2006 Aug 27; 26(8):1078-85. PubMed ID: 16863484
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy.
    Burger AJ, Elkayam U, Neibaur MT, Haught H, Ghali J, Horton DP, Aronson D.
    Am J Cardiol; 2001 Jul 01; 88(1):35-9. PubMed ID: 11423055
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
    Adamopoulos S, Parissis JT, Iliodromitis EK, Paraskevaidis I, Tsiapras D, Farmakis D, Karatzas D, Gheorghiade M, Filippatos GS, Kremastinos DT.
    Am J Cardiol; 2006 Jul 01; 98(1):102-6. PubMed ID: 16784930
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of nesiritide in combination with standard therapy on serum concentrations of natriuretic peptides in patients admitted for decompensated congestive heart failure.
    Fitzgerald RL, Cremo R, Gardetto N, Chiu A, Clopton P, Bhalla V, Maisel AS.
    Am Heart J; 2005 Sep 01; 150(3):471-7. PubMed ID: 16169326
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: a multicenter clinical outcomes trial using nesiritide for TMAC.
    Mehra MR, McCluskey T, Barr M, Bourge RC, Jessup ML, Mancini D, Radovancevic B, Rayburn B, Taylor DO, Lilly-Hersley J, Linde P.
    Am Heart J; 2007 Jun 01; 153(6):932-40. PubMed ID: 17540193
    [Abstract] [Full Text] [Related]

  • 16. Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.
    Cohen-Solal A, Logeart D, Huang B, Cai D, Nieminen MS, Mebazaa A.
    J Am Coll Cardiol; 2009 Jun 23; 53(25):2343-8. PubMed ID: 19539144
    [Abstract] [Full Text] [Related]

  • 17. Neurohumoral activation and ventricular arrhythmias in patients with decompensated congestive heart failure: role of endothelin.
    Aronson D, Burger AJ.
    Pacing Clin Electrophysiol; 2003 Mar 23; 26(3):703-10. PubMed ID: 12698670
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.